This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US

ONLINE REGISTRATION CLOSES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024

Alistair Hurst
Director of Business Development (Global) at emp Biotech GmbH
Speaker

Profile

Alistair Hurst is the Director of Business Development (Global) at emp BIOTECH and also functions as the General Manager of the company’s US subsidiary. With a background in chemical engineering and inorganic chemistry, he has spent the last 30 years engaged in protein purification projects and has developed several products which have been taken into the commercial space. These have been in diagnostic, analytical, therapeutic and environmental application areas. In collaboration with his Berlin-based colleagues he has designed and developed the company’s new Protein G solid phase which is the first to be truly base-stable.

Agenda Sessions

  • A Base-Stable Protein G Solid Phase for the Purification of Human Monoclonal Antibodies

    7:30am